mouse il 1β Search Results


94
MedChemExpress interleukin 1 beta
Interleukin 1 Beta, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+il+1%CE%B2/IL-1+beta%2C+Mouse/pmc09655594-66-14-21
Average 94 stars, based on 1 article reviews
interleukin 1 beta - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

98
Multi Sciences (Lianke) Biotech Co Ltd il 1β
Il 1β, supplied by Multi Sciences (Lianke) Biotech Co Ltd, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+il+1%CE%B2/Mouse+IL-1%CE%B2+ELISA+Kit/pm38414786-73-20-27
Average 98 stars, based on 1 article reviews
il 1β - by Bioz Stars, 2026-11
98/100 stars
  Buy from Supplier

95
Beijing Solarbio Science mouse il 1β elisa kit
Mouse Il 1β Elisa Kit, supplied by Beijing Solarbio Science, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+il+1%CE%B2/Mouse+IL-1%CE%B2+ELISA+KIT-96T/pmc08042336-94-20-37
Average 95 stars, based on 1 article reviews
mouse il 1β elisa kit - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

97
Elabscience Biotechnology il 1β
Il 1β, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+il+1%CE%B2/Mouse+IL-1%CE%B2+(Interleukin+1+Beta)+ELISA+Kit/10__3390_slash_ph19010113-167-3-18
Average 97 stars, based on 1 article reviews
il 1β - by Bioz Stars, 2026-11
97/100 stars
  Buy from Supplier

91
Revvity mouse il 1β
Mouse Il 1β, supplied by Revvity, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+il+1%CE%B2/IL-1%CE%B2+(mouse)%2C+lyophilized/pmc05386297-103-2-13
Average 91 stars, based on 1 article reviews
mouse il 1β - by Bioz Stars, 2026-11
91/100 stars
  Buy from Supplier

96
Cusabio il 1β
CD177 is elevated in patients with NLRP3-AID. ( A ) Venn diagram shows the results of the transcriptome sequencing analysis. ( B ) Heatmap shows differentially expressed genes. ( C ) Flow cytometry detects the expression of CD177 in peripheral blood of NLRP3 mutant patient (PT) and healthy controls (H). ( D ) GEPIA analysis of the expression of CD177 in different immune cells in peripheral blood. ( E ) qPCR assay detects CD177 expression in peripheral blood neutrophils. ( F , G ) qPCR assay detects the expression of CD177 in neutrophils from two healthy controls (H3 and H4) treated with NLRP3 agonist (Nigericin) or NLRP3 inhibitor (CY-09). ( H – K ) qPCR assay detects the expression of <t>IL-1β,</t> IL-6, TNFα and IL-18 in neutrophils from HCs treated with Nigericin or CY-09. ( L ) GEPIA analysis of the expression correlation between CD177 and IL-1β. ( M ) qPCR assay examines the expression of CD177 in MCF-7 cells transfected with CD177 siRNA or negative control siRNA. ( N ) Western blot analysis of CD177 protein levels in MCF-7 cells transfected with CD177 siRNA or negative control siRNA. ( O ) The mRNA levels of IL-1β, IL-6, TNFα and IL-18 in MCF-7 cells transfected with CD177 siRNA or negative control siRNA. qPCR Data are shown as mean ± s.d. Student’s t -test was used. Statistical significance was determined as * p < 0.05; *** p < 0.001.
Il 1β, supplied by Cusabio, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+il+1%CE%B2/Mouse+Interleukin+1%CE%B2%2CIL-1%CE%B2+ELISA+Kit/pmc13026191-155-19-21
Average 96 stars, based on 1 article reviews
il 1β - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

96
Bio X Cell anti mouse pd l1 antibody be0246
CD177 is elevated in patients with NLRP3-AID. ( A ) Venn diagram shows the results of the transcriptome sequencing analysis. ( B ) Heatmap shows differentially expressed genes. ( C ) Flow cytometry detects the expression of CD177 in peripheral blood of NLRP3 mutant patient (PT) and healthy controls (H). ( D ) GEPIA analysis of the expression of CD177 in different immune cells in peripheral blood. ( E ) qPCR assay detects CD177 expression in peripheral blood neutrophils. ( F , G ) qPCR assay detects the expression of CD177 in neutrophils from two healthy controls (H3 and H4) treated with NLRP3 agonist (Nigericin) or NLRP3 inhibitor (CY-09). ( H – K ) qPCR assay detects the expression of <t>IL-1β,</t> IL-6, TNFα and IL-18 in neutrophils from HCs treated with Nigericin or CY-09. ( L ) GEPIA analysis of the expression correlation between CD177 and IL-1β. ( M ) qPCR assay examines the expression of CD177 in MCF-7 cells transfected with CD177 siRNA or negative control siRNA. ( N ) Western blot analysis of CD177 protein levels in MCF-7 cells transfected with CD177 siRNA or negative control siRNA. ( O ) The mRNA levels of IL-1β, IL-6, TNFα and IL-18 in MCF-7 cells transfected with CD177 siRNA or negative control siRNA. qPCR Data are shown as mean ± s.d. Student’s t -test was used. Statistical significance was determined as * p < 0.05; *** p < 0.001.
Anti Mouse Pd L1 Antibody Be0246, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+il+1%CE%B2/InVivoMAb+anti-mouse+rat+IL-1%CE%B2/pmc12590479-55-1-8
Average 96 stars, based on 1 article reviews
anti mouse pd l1 antibody be0246 - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

95
Multi Sciences (Lianke) Biotech Co Ltd elisa kits
CD177 is elevated in patients with NLRP3-AID. ( A ) Venn diagram shows the results of the transcriptome sequencing analysis. ( B ) Heatmap shows differentially expressed genes. ( C ) Flow cytometry detects the expression of CD177 in peripheral blood of NLRP3 mutant patient (PT) and healthy controls (H). ( D ) GEPIA analysis of the expression of CD177 in different immune cells in peripheral blood. ( E ) qPCR assay detects CD177 expression in peripheral blood neutrophils. ( F , G ) qPCR assay detects the expression of CD177 in neutrophils from two healthy controls (H3 and H4) treated with NLRP3 agonist (Nigericin) or NLRP3 inhibitor (CY-09). ( H – K ) qPCR assay detects the expression of <t>IL-1β,</t> IL-6, TNFα and IL-18 in neutrophils from HCs treated with Nigericin or CY-09. ( L ) GEPIA analysis of the expression correlation between CD177 and IL-1β. ( M ) qPCR assay examines the expression of CD177 in MCF-7 cells transfected with CD177 siRNA or negative control siRNA. ( N ) Western blot analysis of CD177 protein levels in MCF-7 cells transfected with CD177 siRNA or negative control siRNA. ( O ) The mRNA levels of IL-1β, IL-6, TNFα and IL-18 in MCF-7 cells transfected with CD177 siRNA or negative control siRNA. qPCR Data are shown as mean ± s.d. Student’s t -test was used. Statistical significance was determined as * p < 0.05; *** p < 0.001.
Elisa Kits, supplied by Multi Sciences (Lianke) Biotech Co Ltd, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+il+1%CE%B2/Mouse+IL-1%CE%B2+High+Sensitivity+ELISA+Kit/pmc13178157-87-0-5
Average 95 stars, based on 1 article reviews
elisa kits - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

95
Elabscience Biotechnology q711 02 mouse interleukin 1β il 1β elisa kit elabscience
CD177 is elevated in patients with NLRP3-AID. ( A ) Venn diagram shows the results of the transcriptome sequencing analysis. ( B ) Heatmap shows differentially expressed genes. ( C ) Flow cytometry detects the expression of CD177 in peripheral blood of NLRP3 mutant patient (PT) and healthy controls (H). ( D ) GEPIA analysis of the expression of CD177 in different immune cells in peripheral blood. ( E ) qPCR assay detects CD177 expression in peripheral blood neutrophils. ( F , G ) qPCR assay detects the expression of CD177 in neutrophils from two healthy controls (H3 and H4) treated with NLRP3 agonist (Nigericin) or NLRP3 inhibitor (CY-09). ( H – K ) qPCR assay detects the expression of <t>IL-1β,</t> IL-6, TNFα and IL-18 in neutrophils from HCs treated with Nigericin or CY-09. ( L ) GEPIA analysis of the expression correlation between CD177 and IL-1β. ( M ) qPCR assay examines the expression of CD177 in MCF-7 cells transfected with CD177 siRNA or negative control siRNA. ( N ) Western blot analysis of CD177 protein levels in MCF-7 cells transfected with CD177 siRNA or negative control siRNA. ( O ) The mRNA levels of IL-1β, IL-6, TNFα and IL-18 in MCF-7 cells transfected with CD177 siRNA or negative control siRNA. qPCR Data are shown as mean ± s.d. Student’s t -test was used. Statistical significance was determined as * p < 0.05; *** p < 0.001.
Q711 02 Mouse Interleukin 1β Il 1β Elisa Kit Elabscience, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+il+1%CE%B2/Mini+Sample+Mouse+IL-1%CE%B2+(Interleukin+1+Beta)+ELISA+Kit/pm39520088-316-199-206
Average 95 stars, based on 1 article reviews
q711 02 mouse interleukin 1β il 1β elisa kit elabscience - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

94
Miltenyi Biotec mouse il 1β
CD177 is elevated in patients with NLRP3-AID. ( A ) Venn diagram shows the results of the transcriptome sequencing analysis. ( B ) Heatmap shows differentially expressed genes. ( C ) Flow cytometry detects the expression of CD177 in peripheral blood of NLRP3 mutant patient (PT) and healthy controls (H). ( D ) GEPIA analysis of the expression of CD177 in different immune cells in peripheral blood. ( E ) qPCR assay detects CD177 expression in peripheral blood neutrophils. ( F , G ) qPCR assay detects the expression of CD177 in neutrophils from two healthy controls (H3 and H4) treated with NLRP3 agonist (Nigericin) or NLRP3 inhibitor (CY-09). ( H – K ) qPCR assay detects the expression of <t>IL-1β,</t> IL-6, TNFα and IL-18 in neutrophils from HCs treated with Nigericin or CY-09. ( L ) GEPIA analysis of the expression correlation between CD177 and IL-1β. ( M ) qPCR assay examines the expression of CD177 in MCF-7 cells transfected with CD177 siRNA or negative control siRNA. ( N ) Western blot analysis of CD177 protein levels in MCF-7 cells transfected with CD177 siRNA or negative control siRNA. ( O ) The mRNA levels of IL-1β, IL-6, TNFα and IL-18 in MCF-7 cells transfected with CD177 siRNA or negative control siRNA. qPCR Data are shown as mean ± s.d. Student’s t -test was used. Statistical significance was determined as * p < 0.05; *** p < 0.001.
Mouse Il 1β, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+il+1%CE%B2/Mouse+IL-1%CE%B2%2C+premium+grade/bio_rxiv__2024__06__05__597633-67-51-54
Average 94 stars, based on 1 article reviews
mouse il 1β - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

97
TargetMol il 1β
<t>IL-1β</t> <t>promoted</t> tumor growth and immunosuppressive TME formation. A Schematic diagram showing the process for establishing the subcutaneous tumor models and treatments. B Images of isolated tumors from 3 groups ( n = 6). C Tumor growth after tumor cells injection and treatment. D Tumor weight after 24 days injection and treatment. E – H Flow Cytometry showing the average percentage of CD4+T cells ( E ), CD8+T cells ( F ), Tregs ( G ) and M2 macrophages (CD206, H ). I , J The proportion of IL1R2+Treg in Tregs ( I ) and the expression of IL1R2 in Treg ( J ). K Expression of CTLA4 and Tim3 in Tregs. L Expression and analysis of Granzyme B, Perforin and CTLA4 in CD8+T cells. i.t., intratumor injection. α-il1r1: anti-IL1R1. rmIL-1β: recombinant murine IL-1β. ns, no significance; * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001
Il 1β, supplied by TargetMol, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+il+1%CE%B2/IL-1+beta-IL-1F2+Protein%2C+Mouse%2C+Recombinant/pmc11936857-38-14-17
Average 97 stars, based on 1 article reviews
il 1β - by Bioz Stars, 2026-11
97/100 stars
  Buy from Supplier

94
Miltenyi Biotec research grade miltenyi biotec
<t>IL-1β</t> <t>promoted</t> tumor growth and immunosuppressive TME formation. A Schematic diagram showing the process for establishing the subcutaneous tumor models and treatments. B Images of isolated tumors from 3 groups ( n = 6). C Tumor growth after tumor cells injection and treatment. D Tumor weight after 24 days injection and treatment. E – H Flow Cytometry showing the average percentage of CD4+T cells ( E ), CD8+T cells ( F ), Tregs ( G ) and M2 macrophages (CD206, H ). I , J The proportion of IL1R2+Treg in Tregs ( I ) and the expression of IL1R2 in Treg ( J ). K Expression of CTLA4 and Tim3 in Tregs. L Expression and analysis of Granzyme B, Perforin and CTLA4 in CD8+T cells. i.t., intratumor injection. α-il1r1: anti-IL1R1. rmIL-1β: recombinant murine IL-1β. ns, no significance; * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001
Research Grade Miltenyi Biotec, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+il+1%CE%B2/Mouse+IL-1%CE%B2%2C+research+grade/pm38986617-253-185-187
Average 94 stars, based on 1 article reviews
research grade miltenyi biotec - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

Image Search Results


CD177 is elevated in patients with NLRP3-AID. ( A ) Venn diagram shows the results of the transcriptome sequencing analysis. ( B ) Heatmap shows differentially expressed genes. ( C ) Flow cytometry detects the expression of CD177 in peripheral blood of NLRP3 mutant patient (PT) and healthy controls (H). ( D ) GEPIA analysis of the expression of CD177 in different immune cells in peripheral blood. ( E ) qPCR assay detects CD177 expression in peripheral blood neutrophils. ( F , G ) qPCR assay detects the expression of CD177 in neutrophils from two healthy controls (H3 and H4) treated with NLRP3 agonist (Nigericin) or NLRP3 inhibitor (CY-09). ( H – K ) qPCR assay detects the expression of IL-1β, IL-6, TNFα and IL-18 in neutrophils from HCs treated with Nigericin or CY-09. ( L ) GEPIA analysis of the expression correlation between CD177 and IL-1β. ( M ) qPCR assay examines the expression of CD177 in MCF-7 cells transfected with CD177 siRNA or negative control siRNA. ( N ) Western blot analysis of CD177 protein levels in MCF-7 cells transfected with CD177 siRNA or negative control siRNA. ( O ) The mRNA levels of IL-1β, IL-6, TNFα and IL-18 in MCF-7 cells transfected with CD177 siRNA or negative control siRNA. qPCR Data are shown as mean ± s.d. Student’s t -test was used. Statistical significance was determined as * p < 0.05; *** p < 0.001.

Journal: International Journal of Molecular Sciences

Article Title: Targeting CD177: A Novel Therapeutic Strategy for NLRP3-Associated Autoinflammatory Diseases

doi: 10.3390/ijms27062841

Figure Lengend Snippet: CD177 is elevated in patients with NLRP3-AID. ( A ) Venn diagram shows the results of the transcriptome sequencing analysis. ( B ) Heatmap shows differentially expressed genes. ( C ) Flow cytometry detects the expression of CD177 in peripheral blood of NLRP3 mutant patient (PT) and healthy controls (H). ( D ) GEPIA analysis of the expression of CD177 in different immune cells in peripheral blood. ( E ) qPCR assay detects CD177 expression in peripheral blood neutrophils. ( F , G ) qPCR assay detects the expression of CD177 in neutrophils from two healthy controls (H3 and H4) treated with NLRP3 agonist (Nigericin) or NLRP3 inhibitor (CY-09). ( H – K ) qPCR assay detects the expression of IL-1β, IL-6, TNFα and IL-18 in neutrophils from HCs treated with Nigericin or CY-09. ( L ) GEPIA analysis of the expression correlation between CD177 and IL-1β. ( M ) qPCR assay examines the expression of CD177 in MCF-7 cells transfected with CD177 siRNA or negative control siRNA. ( N ) Western blot analysis of CD177 protein levels in MCF-7 cells transfected with CD177 siRNA or negative control siRNA. ( O ) The mRNA levels of IL-1β, IL-6, TNFα and IL-18 in MCF-7 cells transfected with CD177 siRNA or negative control siRNA. qPCR Data are shown as mean ± s.d. Student’s t -test was used. Statistical significance was determined as * p < 0.05; *** p < 0.001.

Article Snippet: The levels of IL-1β and IL-6 in the serum were detected using mouse-specific IL-6 (CSB-E04639m, Cusabio, Wuhan, China) and IL-1β (CSB-E08054m, Cusabio, Wuhan, China) detection kits according to the manufacturer’s instructions.

Techniques: Sequencing, Flow Cytometry, Expressing, Mutagenesis, Transfection, Negative Control, Western Blot

NLRP3 mutant mice exhibit phenotypic heterogeneity despite identical genotypes. ( A ) Images of wild-type ( Nlrp3 +/+ ) mice and NLRP3 mutant ( Nlrp3 L573W/+ ) mice with different inflammatory states. Notably, both mild and severe phenotypic groups are confirmed to be heterozygous for the p.L573W mutation. ( B ) Body weight of wild-type mice, NLRP3 mutant (Nlrp3 L573W/+) mice with different inflammatory states (weight measured starting from day 12, every other day). ( C ) Flow cytometry analysis of neutrophils in mouse peripheral blood ( n = 6 per group). ( D – F ) Histopathological detection of mouse tissues (skin, liver, spleen) showing varying degrees of inflammatory infiltration, Scale bars: 400 μm, 100 μm. ( G – I ) Immunohistochemical detection of mouse tissues (skin, liver, spleen) showing differences in neutrophil marker Ly6G expression, Scale bars: 200 μm, 50 μm. ( J ) Cytokine microarray in serum of wild-type mice and NLRP3 mutant mice with different inflammatory states. ( K , L ) Flow cytometry detection of IL-1β and IL-6 protein expression in mouse peripheral blood cells ( n = 6 per group). ( M – O ) qPCR detection of IL-1β, IL-6, and TNFα mRNA expression levels in mouse skin, liver, and spleen tissues ( n = 3). qPCR Data are shown as mean ± s.d. Student’s t -test was used. Statistical significance was determined as ** p < 0.01; *** p < 0.001; ns, not significant. CD177 expression is elevated in NLRP3 mutant mice and correlates with disease severity.

Journal: International Journal of Molecular Sciences

Article Title: Targeting CD177: A Novel Therapeutic Strategy for NLRP3-Associated Autoinflammatory Diseases

doi: 10.3390/ijms27062841

Figure Lengend Snippet: NLRP3 mutant mice exhibit phenotypic heterogeneity despite identical genotypes. ( A ) Images of wild-type ( Nlrp3 +/+ ) mice and NLRP3 mutant ( Nlrp3 L573W/+ ) mice with different inflammatory states. Notably, both mild and severe phenotypic groups are confirmed to be heterozygous for the p.L573W mutation. ( B ) Body weight of wild-type mice, NLRP3 mutant (Nlrp3 L573W/+) mice with different inflammatory states (weight measured starting from day 12, every other day). ( C ) Flow cytometry analysis of neutrophils in mouse peripheral blood ( n = 6 per group). ( D – F ) Histopathological detection of mouse tissues (skin, liver, spleen) showing varying degrees of inflammatory infiltration, Scale bars: 400 μm, 100 μm. ( G – I ) Immunohistochemical detection of mouse tissues (skin, liver, spleen) showing differences in neutrophil marker Ly6G expression, Scale bars: 200 μm, 50 μm. ( J ) Cytokine microarray in serum of wild-type mice and NLRP3 mutant mice with different inflammatory states. ( K , L ) Flow cytometry detection of IL-1β and IL-6 protein expression in mouse peripheral blood cells ( n = 6 per group). ( M – O ) qPCR detection of IL-1β, IL-6, and TNFα mRNA expression levels in mouse skin, liver, and spleen tissues ( n = 3). qPCR Data are shown as mean ± s.d. Student’s t -test was used. Statistical significance was determined as ** p < 0.01; *** p < 0.001; ns, not significant. CD177 expression is elevated in NLRP3 mutant mice and correlates with disease severity.

Article Snippet: The levels of IL-1β and IL-6 in the serum were detected using mouse-specific IL-6 (CSB-E04639m, Cusabio, Wuhan, China) and IL-1β (CSB-E08054m, Cusabio, Wuhan, China) detection kits according to the manufacturer’s instructions.

Techniques: Mutagenesis, Flow Cytometry, Immunohistochemical staining, Marker, Expressing, Microarray

Targeted IL-6 therapy is ineffective for NLRP3 mutation-induced AID. ( A – G ) Flow cytometry detection of neutrophil, IL-1β, IL-6 and CD177 protein expression in peripheral blood of NLRP3 mutant severe mice treated with or without IL-6 antibody ( n = 7). ( H – K ) qPCR detection of IL-1β, IL-6, TNFα and CD177 mRNA expression levels in skin, liver, and spleen tissues of NLRP3 mutant severe mice treated with or without IL-6 antibody ( n = 3). ( L – N ) Histopathological detection of mouse tissues (skin, liver, spleen), Scale bars: 400 μm, 100 μm. ( O – Q ) Immunohistochemical detection of Ly6G levels in mouse skin, liver, spleen tissues, Scale bars:200 μm, 50 μm. qPCR Data are shown as mean ± s.d. Student’s t -test was used. Statistical significance was determined as * p < 0.05; ** p < 0.01; *** p < 0.001; ns, not significant.

Journal: International Journal of Molecular Sciences

Article Title: Targeting CD177: A Novel Therapeutic Strategy for NLRP3-Associated Autoinflammatory Diseases

doi: 10.3390/ijms27062841

Figure Lengend Snippet: Targeted IL-6 therapy is ineffective for NLRP3 mutation-induced AID. ( A – G ) Flow cytometry detection of neutrophil, IL-1β, IL-6 and CD177 protein expression in peripheral blood of NLRP3 mutant severe mice treated with or without IL-6 antibody ( n = 7). ( H – K ) qPCR detection of IL-1β, IL-6, TNFα and CD177 mRNA expression levels in skin, liver, and spleen tissues of NLRP3 mutant severe mice treated with or without IL-6 antibody ( n = 3). ( L – N ) Histopathological detection of mouse tissues (skin, liver, spleen), Scale bars: 400 μm, 100 μm. ( O – Q ) Immunohistochemical detection of Ly6G levels in mouse skin, liver, spleen tissues, Scale bars:200 μm, 50 μm. qPCR Data are shown as mean ± s.d. Student’s t -test was used. Statistical significance was determined as * p < 0.05; ** p < 0.01; *** p < 0.001; ns, not significant.

Article Snippet: The levels of IL-1β and IL-6 in the serum were detected using mouse-specific IL-6 (CSB-E04639m, Cusabio, Wuhan, China) and IL-1β (CSB-E08054m, Cusabio, Wuhan, China) detection kits according to the manufacturer’s instructions.

Techniques: Mutagenesis, Flow Cytometry, Expressing, Immunohistochemical staining

Targeting CD177 reverses the inflammatory phenotype of NLRP3 -AID mice. ( A , B ) Flow cytometry detection of CD177 protein expression in peripheral blood of mice treated with either IL-1β antibody or CD177 siRNA ( n = 6). ( C ) qPCR detection of CD177 mRNA expression levels in mouse skin, liver, and spleen tissues ( n = 3). ( D ) Treatment was initiated on Day 14. Body weights were recorded every two days to evaluate systemic recovery. Data are presented as mean ± SEM ( n = 6 per group). ( E ) Flow cytometry detection of neutrophils in mouse peripheral blood after treatment with either IL-1β antibody or CD177 siRNA ( n = 6). ( F – H ) Histopathological detection of mouse tissues (skin, liver, spleen), Scale bars: 400 μm, 100 μm. ( I – K ) Immunohistochemical detection of Ly6G protein expression in mouse tissues (skin, liver, spleen), Scale bars: 200 μm, 50 μm. qPCR data are shown as mean ± s.d. Student’s t -test was used. Statistical significance was determined as *** p < 0.001.

Journal: International Journal of Molecular Sciences

Article Title: Targeting CD177: A Novel Therapeutic Strategy for NLRP3-Associated Autoinflammatory Diseases

doi: 10.3390/ijms27062841

Figure Lengend Snippet: Targeting CD177 reverses the inflammatory phenotype of NLRP3 -AID mice. ( A , B ) Flow cytometry detection of CD177 protein expression in peripheral blood of mice treated with either IL-1β antibody or CD177 siRNA ( n = 6). ( C ) qPCR detection of CD177 mRNA expression levels in mouse skin, liver, and spleen tissues ( n = 3). ( D ) Treatment was initiated on Day 14. Body weights were recorded every two days to evaluate systemic recovery. Data are presented as mean ± SEM ( n = 6 per group). ( E ) Flow cytometry detection of neutrophils in mouse peripheral blood after treatment with either IL-1β antibody or CD177 siRNA ( n = 6). ( F – H ) Histopathological detection of mouse tissues (skin, liver, spleen), Scale bars: 400 μm, 100 μm. ( I – K ) Immunohistochemical detection of Ly6G protein expression in mouse tissues (skin, liver, spleen), Scale bars: 200 μm, 50 μm. qPCR data are shown as mean ± s.d. Student’s t -test was used. Statistical significance was determined as *** p < 0.001.

Article Snippet: The levels of IL-1β and IL-6 in the serum were detected using mouse-specific IL-6 (CSB-E04639m, Cusabio, Wuhan, China) and IL-1β (CSB-E08054m, Cusabio, Wuhan, China) detection kits according to the manufacturer’s instructions.

Techniques: Flow Cytometry, Expressing, Immunohistochemical staining

Targeting CD177 suppresses the expression of IL-1β. ( A , B ) Flow cytometry detection of IL-1β protein expression levels in peripheral blood of mice treated with either IL-1β antibody or CD177 siRNA ( n = 6). ( C ) ELISA detection of serum IL-1β protein levels in mice treated with either IL-1β antibody or CD177 siRNA ( n = 3). ( D , E ) Flow cytometry detection of IL-6 protein expression levels in peripheral blood of mice treated with either anti-IL-1β antibody or CD177 siRNA ( n = 6). ( F ) ELISA detection of serum IL-6 protein levels in mice treated with either IL-1β antibody or CD177 siRNA ( n = 3). ( G – I ) qPCR detection of IL-6, IL-1β, and TNFα mRNA expression levels in mouse skin, liver, and spleen tissues ( n = 3). ( J ) Schematic diagram shows the role of CD177 in the development of NLRP3 mutation-related autoinflammation. qPCR Data are shown as mean ± s.d. Student’s t -test was used. Statistical significance was determined as ** p < 0.01; *** p < 0.001.

Journal: International Journal of Molecular Sciences

Article Title: Targeting CD177: A Novel Therapeutic Strategy for NLRP3-Associated Autoinflammatory Diseases

doi: 10.3390/ijms27062841

Figure Lengend Snippet: Targeting CD177 suppresses the expression of IL-1β. ( A , B ) Flow cytometry detection of IL-1β protein expression levels in peripheral blood of mice treated with either IL-1β antibody or CD177 siRNA ( n = 6). ( C ) ELISA detection of serum IL-1β protein levels in mice treated with either IL-1β antibody or CD177 siRNA ( n = 3). ( D , E ) Flow cytometry detection of IL-6 protein expression levels in peripheral blood of mice treated with either anti-IL-1β antibody or CD177 siRNA ( n = 6). ( F ) ELISA detection of serum IL-6 protein levels in mice treated with either IL-1β antibody or CD177 siRNA ( n = 3). ( G – I ) qPCR detection of IL-6, IL-1β, and TNFα mRNA expression levels in mouse skin, liver, and spleen tissues ( n = 3). ( J ) Schematic diagram shows the role of CD177 in the development of NLRP3 mutation-related autoinflammation. qPCR Data are shown as mean ± s.d. Student’s t -test was used. Statistical significance was determined as ** p < 0.01; *** p < 0.001.

Article Snippet: The levels of IL-1β and IL-6 in the serum were detected using mouse-specific IL-6 (CSB-E04639m, Cusabio, Wuhan, China) and IL-1β (CSB-E08054m, Cusabio, Wuhan, China) detection kits according to the manufacturer’s instructions.

Techniques: Expressing, Flow Cytometry, Enzyme-linked Immunosorbent Assay, Mutagenesis

IL-1β promoted tumor growth and immunosuppressive TME formation. A Schematic diagram showing the process for establishing the subcutaneous tumor models and treatments. B Images of isolated tumors from 3 groups ( n = 6). C Tumor growth after tumor cells injection and treatment. D Tumor weight after 24 days injection and treatment. E – H Flow Cytometry showing the average percentage of CD4+T cells ( E ), CD8+T cells ( F ), Tregs ( G ) and M2 macrophages (CD206, H ). I , J The proportion of IL1R2+Treg in Tregs ( I ) and the expression of IL1R2 in Treg ( J ). K Expression of CTLA4 and Tim3 in Tregs. L Expression and analysis of Granzyme B, Perforin and CTLA4 in CD8+T cells. i.t., intratumor injection. α-il1r1: anti-IL1R1. rmIL-1β: recombinant murine IL-1β. ns, no significance; * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001

Journal: Cancer Immunology, Immunotherapy : CII

Article Title: Single-cell RNA sequencing reveals an IL1R2+Treg subset driving immunosuppressive microenvironment in HNSCC

doi: 10.1007/s00262-025-04015-1

Figure Lengend Snippet: IL-1β promoted tumor growth and immunosuppressive TME formation. A Schematic diagram showing the process for establishing the subcutaneous tumor models and treatments. B Images of isolated tumors from 3 groups ( n = 6). C Tumor growth after tumor cells injection and treatment. D Tumor weight after 24 days injection and treatment. E – H Flow Cytometry showing the average percentage of CD4+T cells ( E ), CD8+T cells ( F ), Tregs ( G ) and M2 macrophages (CD206, H ). I , J The proportion of IL1R2+Treg in Tregs ( I ) and the expression of IL1R2 in Treg ( J ). K Expression of CTLA4 and Tim3 in Tregs. L Expression and analysis of Granzyme B, Perforin and CTLA4 in CD8+T cells. i.t., intratumor injection. α-il1r1: anti-IL1R1. rmIL-1β: recombinant murine IL-1β. ns, no significance; * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001

Article Snippet: Tregs induced by naive CD4+T cells from the spleen of C57BL/6 mice, treated with IL-1β (50 ng/ml, TargetMol, #TMPY-02134).

Techniques: Isolation, Injection, Flow Cytometry, Expressing, Recombinant

IL-1β promoted the expression of the CTLA4 by regulating NR4A1. A Representative mIHC staining of CD4 (green), FOXP3 (red), IL1R2 (violet), IL-1β (cyan) in human HNSCC tissues. Tregs (yellow) were identified using colocalization of CD4 and FOXP3. Intensity of IL1R2+Treg (violet) and IL-1β (cyan) was calculated using ImageJ according to the line on picture. Scale bar, left, 20 μm; right, 10 μm. B Flow Cytometry showing the expression of IL1R2 in Tregs after treating with recombinant murine IL-1β for 12 h. C Volcano Plot showing significant down-regulated and up-regulated nuclear protein after treating with rmIL-1β (50 ng/mL) measured by Pro DIA quantitative proteomics. D Venn diagram showed 16 genes both up-regulated significantly in rmIL-1β group and worked as transcription factor. E , F The expression of CTLA4 in Tregs after using DIM-C-pPhOH (NR4A1 inhibitor, 20 μM, 24 h) and 4μ8C (IRE1 inhibitor, 200 nM, 24 h) with (F) or without (E) treating with rmIL-1β. G The expression of NR4A1 in nucleus in Tregs after stimulating with rmIL-1β or blocking IL1R2. H The location and intensity of NR4A1 in Tregs with different treatments. Scale bar, left, 2 μm; right, 1 μm. Intensity of NR4A1 (red) and DAPI (blue) was calculated using ImageJ according to the line on picture. ns, no significance; * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001

Journal: Cancer Immunology, Immunotherapy : CII

Article Title: Single-cell RNA sequencing reveals an IL1R2+Treg subset driving immunosuppressive microenvironment in HNSCC

doi: 10.1007/s00262-025-04015-1

Figure Lengend Snippet: IL-1β promoted the expression of the CTLA4 by regulating NR4A1. A Representative mIHC staining of CD4 (green), FOXP3 (red), IL1R2 (violet), IL-1β (cyan) in human HNSCC tissues. Tregs (yellow) were identified using colocalization of CD4 and FOXP3. Intensity of IL1R2+Treg (violet) and IL-1β (cyan) was calculated using ImageJ according to the line on picture. Scale bar, left, 20 μm; right, 10 μm. B Flow Cytometry showing the expression of IL1R2 in Tregs after treating with recombinant murine IL-1β for 12 h. C Volcano Plot showing significant down-regulated and up-regulated nuclear protein after treating with rmIL-1β (50 ng/mL) measured by Pro DIA quantitative proteomics. D Venn diagram showed 16 genes both up-regulated significantly in rmIL-1β group and worked as transcription factor. E , F The expression of CTLA4 in Tregs after using DIM-C-pPhOH (NR4A1 inhibitor, 20 μM, 24 h) and 4μ8C (IRE1 inhibitor, 200 nM, 24 h) with (F) or without (E) treating with rmIL-1β. G The expression of NR4A1 in nucleus in Tregs after stimulating with rmIL-1β or blocking IL1R2. H The location and intensity of NR4A1 in Tregs with different treatments. Scale bar, left, 2 μm; right, 1 μm. Intensity of NR4A1 (red) and DAPI (blue) was calculated using ImageJ according to the line on picture. ns, no significance; * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001

Article Snippet: Tregs induced by naive CD4+T cells from the spleen of C57BL/6 mice, treated with IL-1β (50 ng/ml, TargetMol, #TMPY-02134).

Techniques: Expressing, Staining, Flow Cytometry, Recombinant, Quantitative Proteomics, Blocking Assay